Q: Indications?

1. INDICATIONS AND USAGE Everolimus tablets are a kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ( 1.1 ) Adults with progressive neuroendocrine tumors of pancreatic origin (PNET) and adults with progre

Q: Side Effects?

6. ADVERSE REACTIONS The following serious adverse reactions are described elsewhere in the labeling: Non-Infectious Pneumonitis [see Warnings and Precautions (5.1) ] Infections [see Warnings and Precautions (5.2) ] Severe Hypersensitivity Reactions [see Warnings and Precautions (5.3) ] Angioedema with Concomitant Use of ACE inhibitors [see Warnings and Precautions (5.4) ] Stomat

Q: Contraindications?

4. CONTRAINDICATIONS Everolimus tablets/everolimus tablets for oral suspension are contraindicated in patients with clinically significant hypersensitivity to everolimus or to other rapamycin derivatives [see Warnings and Precautions (5.3) ]. Clinically significant hypersensitivity to everolimus or to other rapamycin derivatives. ( 4 )

Q: Warnings?

Any unused medicinal product or waste material should be disposed of in accordance with local requirements.

Question 1

Indications?

Accepted Answer

1.﻿‍​‍‍‍​‍‍‍‍‍‍‍‍​‍﻿ INDICATIONS AND USAGE Everolimus tablets are a kinase inhibitor indicated for the treatment of: Postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole. ( 1.1 ) Adults with progressive neuroendocrine tumors of pancreatic origin (PNET) and adults with progre

Question 2

Dosage?

Accepted Answer

Everolimus: Tabletki 0,25 mg

Question 3

Side Effects?

Accepted Answer

6.﻿‍​‍‍‍​‍‍‍‍‍‍‍‍​‍﻿ ADVERSE REACTIONS The following serious adverse reactions are described elsewhere in the labeling: Non-Infectious Pneumonitis [see Warnings and Precautions (5.1) ] Infections [see Warnings and Precautions (5.2) ] Severe Hypersensitivity Reactions [see Warnings and Precautions (5.3) ] Angioedema with Concomitant Use of ACE inhibitors [see Warnings and Precautions (5.4) ] Stomat

Question 4

Contraindications?

Accepted Answer

4.﻿‍​‍‍‍​‍‍‍‍‍‍‍‍​‍﻿ CONTRAINDICATIONS Everolimus tablets/everolimus tablets for oral suspension are contraindicated in patients with clinically significant hypersensitivity to everolimus or to other rapamycin derivatives [see Warnings and Precautions (5.3) ]. Clinically significant hypersensitivity to everolimus or to other rapamycin derivatives. ( 4 )

Question 5

Warnings?

Accepted Answer

Any unused medicinal product or was﻿‍​‍‍‍​‍‍‍‍‍‍‍‍​‍﻿te material should be disposed of in accordance with local requirements.

Everolimus

User Reviews